LTBP2 regulates cisplatin resistance in GC cells via activation of the NF-κB2/BCL3 pathway
Jun Wang,
Wenjia Liang,
Xiangwen Wang
et al.
Abstract:Gastric cancer (GC) often develops resistance to cisplatin treatment, but while latent transforming growth factor β-binding protein ( LTBP2) is recognized as a potential regulator in GC, its specific role in cisplatin resistance is not fully understood. This study investigated LTBP2's impact on cisplatin resistance in GC. LTBP2 expression was assessed in various GC cell lines, and its correlation with cisplatin sensitivity was determined through cell viability assays. Lentivirusmediated LTBP2 silencing in HGC-… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.